Skip to main content
. 2003 Feb;77(3):1894–1903. doi: 10.1128/JVI.77.3.1894-1903.2003

TABLE 1.

Injection of sheep with pBLV-IF encoding wild-type or D247G Taxa

Expt no. Injected BLV clone Sheep no. Sex WBC/mm3 PBL/mm3 Age at injection (yr) Provirus detectedb (wk) Antibodies to BLVc
gp51 p24
1 Wild type G250 M 8,000 6,960 1
G279 M 5,000 3,900 1 4 +
G296 M 5,500 4,015 1 8
D247G G245 M 8,200 6,478 1
G287 M 5,000 3,600 1 6 +
G298 M 4,900 4,312 1
pME18Neo (control) G267 M 5,500 3,245 1
G274 M 4,000 2,360 1
2 Wild type W109 M 10,500 7,980 1
W196 M 9,000 7,560 1
B.0249 M 13,600 8,432 1
D247G W195 F 11,100 7,437 1 4 +
B.0234 F 15,700 13,816 1 6 +
B.0240 M 9,000 6,930 1
pBluescript II (control) Or.111 M 9,300 6,789 1
a

Experimental injections were made in 1999 (experiment 1) and 2000 (experiment 2). WBC, white blood cells; PBL, peripheral blood lymphocytes.

b

Blood was periodically collected from each sheep, and total DNA was extracted from the blood and used as the template for PCR for detection of BLV proviral genomes, as described in Materials and Methods. The week at which the BLV proviral genome was first detected is indicated.

c

The BLV antibody in serum from sheep at 15 weeks after injection was detected by use of an immunodiffusion test as described in Materials and Methods. −, negative; +, positive.